Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present AdvanSource Biomaterials Corp. (OTC: ASNB).

Full DD Report for ASNB

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-170.05070.0490.059850.04994,600
2018-12-14N/A0.05635N/AN/A0
2018-12-13N/A0.05635N/AN/A0
2018-12-120.056350.056350.056350.05635700
2018-12-110.056350.056350.056350.056352,500

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1750,10094,60052.9598Short
2018-12-10800800100.0000Short
2018-11-1995,072255,07237.2726Short
2018-11-1534,00035,00097.1429Short
2018-10-3010,00010,10099.0099Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ASNB.


About AdvanSource Biomaterials Corp. (OTC: ASNB)

Logo for AdvanSource Biomaterials Corp. (OTC: ASNB)

lt p gt AdvanSource Biomaterials Corporation manufactures advanced polymer materials providing critical characteristics in medical device design and development. These biomaterials are used in devices designed for treating a broad range of anatomical sites and disease states. AdvanSource s business model leverages its proprietary materials science technology and manufacturing expertise to expand its product sales and royalty and license fee income. lt /p gt

 

 

 

Current Management

  • Michael F. Adams / President, CEO
    • Mr. Adams has been our director since May . Mr. Adams was appointed as our President and Chief Executive Officer on August , . From April , until August , , Mr. Adams was our Vice President of Regulatory Affairs and Business Development. Prior to April , Mr. Adams was the Vice President of PLC Systems, Inc. Prior to joining PLC Systems in September , Mr. Adams was Vice President of Assurance Medical, Inc. Prior to joining Assurance Medical in June , Mr. Adams was the Chief Operating Officer and Vice President of Regulatory Affairs and Quality Assurance of CardioTech from June to May . From November through June , Mr. Adams served as the Vice President of Cytyc Corporation. Mr. Adams received a BS from the University of Massachusetts.
  • David Volpe / Consultant
  • Investor Relations / IR
  • William J. O Neill, Jr. / Chairman, Independent Director, Audit Committee Member
    • Mr. O Neill has been our director since May and was appointed as Chairman on August , . Mr. O Neill is currently the Dean of the Frank Sawyer School of Management at Suffolk University in Boston, Massachusetts. From through , Mr. O Neill held the positions of Executive Vice President of the Corporation, President of Corporate Business Development, and Chief Financial Officer for Polaroid Corporation. He was also Senior Financial Analyst at Ford Motor Company. Mr. O Neill was a Trustee at the Dana Farber Cancer Institute, and is a former member of the Massachusetts Bar Association, a member of the Board of Directors of the Greater Boston Chamber of Commerce, and serves on the Board of Directors of Concord Camera. He earned a BA at Boston College in mathematics, a MBA in finance from Wayne State University, and a JD from Suffolk University Law School.

Current Share Structure

  • Market Cap: $859,625 - 03/09/2018
  • Authorized: 50,000,000 - 12/31/2017
  • Issue and Outstanding: 21,490,621 - 02/12/2018
  • Float: 20,595,263 - 12/09/2016

 


Recent Filings from (OTC: ASNB)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 14 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017

 

 


Daily Technical Chart for (OTC: ASNB)

Daily Technical Chart for (OTC: ASNB)


Stay tuned for daily updates and more on (OTC: ASNB)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ASNB)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ASNB is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ASNB and does not buy, sell, or trade any shares of ASNB. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/